PJC
CRL icon

Phillip James Consulting’s Charles River Laboratories CRL Stock Holding History

Phillip James Consulting’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$454 Hold
2
– – ﹤0.01% 318
2026
Q1 		$1K Buy
+2
New +$371 ﹤0.01% 269

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Phillip James Consulting's CRL Position: Q2 2026 in Review

Phillip James Consulting held its Charles River Laboratories (CRL) position steady in Q2 2026 at 2 shares worth $454. The position accounts for ﹤0.01% of the portfolio, ranked #318.

Phillip James Consulting first reported a position in CRL in Q1 2026 and has held it in 2 quarters since. The position peaked at $1K in Q1 2026. 563 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Phillip James Consulting held 2 shares of Charles River Laboratories worth $454 as of Q2 2026.
  • Phillip James Consulting left its Charles River Laboratories share count unchanged in Q2 2026.
  • Charles River Laboratories made up ﹤0.01% of Phillip James Consulting's portfolio in Q2 2026, its #318 holding.
  • Phillip James Consulting first reported a position in Charles River Laboratories in Q1 2026 and has held it in 2 quarters since.
  • Phillip James Consulting's Charles River Laboratories position peaked at $1K in Q1 2026.
  • 563 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Phillip James Consulting's 13F filing for Q2 2026, filed 28 Jul 2026.